NCI Cancer Bulletin for November 16, 2010 - National Cancer Institute

index:
>> Low-Dose CT Shows Clear Mortality Benefit for Lung Cancer Screening in Heavy Smokers

>> Low-dose helical computed tomography gathers a continual picture, leaving no gaps Uncertain Road for Potential Ewing Sarcoma Therapy

>> Path to the clinic is clouded by lack of biomarkers and mixed results in early trials Featured Clinical Trial: Combination Therapy for Advanced Kaposi Sarcoma

>> Will bevacizumab and liposomal doxorubicin shrink tumors in advanced KS? Families and Scientists Gather to Discuss Research and Treatment for Li-Fraumeni Syndrome

>> Meeting provides participants with opportunity to reflect and recommit
Legislative Update
.The 111th Congress Winds Down

Cancer.gov Update
.Boletín Showcases New Design and More Features

Notes
.Biospecimens from SELECT and PCPT Now Available
.Fraumeni Recognized for Achievements by American Cancer Society, American Italian Cancer Foundation
.NCI Recognizes Clinical Investigators with Team Leadership Award
.New Brochure on Biospecimens Available
.New Issue of Cancer Health Disparities Newsletter Released
.NCI Exhibit Booth Wins APHA Award

open here to see the full-contents:
NCI Cancer Bulletin for November 16, 2010 - National Cancer Institute